West Pharmaceutical Services EBITDA Margin 2010-2024 | WST

West Pharmaceutical Services ebitda margin for the quarter ending September 30, 2024 was 25.1%.

  • West Pharmaceutical Services average ebitda margin for 2023 was 27.49%, a 10.43% decline from 2022.
  • West Pharmaceutical Services average ebitda margin for 2022 was 30.69%, a 6.45% decline from 2021.
  • West Pharmaceutical Services average ebitda margin for 2021 was 28.83%, a 25.02% increase from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

West Pharmaceutical Services EBITDA Margin 2010-2024 | WST

  • West Pharmaceutical Services average ebitda margin for 2023 was 27.49%, a 10.43% decline from 2022.
  • West Pharmaceutical Services average ebitda margin for 2022 was 30.69%, a 6.45% decline from 2021.
  • West Pharmaceutical Services average ebitda margin for 2021 was 28.83%, a 25.02% increase from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.